PLTT — Pilot Therapeutics Holdings Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for Pilot Therapeutics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
1998 December 31st | 1999 December 31st | 2000 December 31st | 2001 December 31st | 2002 December 31st | |
---|---|---|---|---|---|
Period Length: | 4 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10KSB | 10KSB |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.193 | 0.853 | 1.62 | 6.93 | 5.39 |
Operating Profit | -0.193 | -0.853 | -1.62 | -6.93 | -5.39 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.188 | -0.84 | -1.72 | -7.09 | -6.37 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.188 | -0.84 | -1.72 | -7.09 | -6.37 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.188 | -0.84 | -1.72 | -7.09 | -6.37 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.188 | -0.84 | -1.72 | -7.57 | -6.37 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.024 | -0.107 | -0.218 | -0.778 | -0.586 |
Dividends per Share |